| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 104.348 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 92.19 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 84.5742 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 80.8045 | 72 |
| GSM780720 | Untreated after 4 days (C2_2) | 96.9841 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 90.2632 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 76.129 | 71 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 94.9792 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 88.9532 | 73 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 66.7843 | 68 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 85.8813 | 73 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 77.7016 | 71 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 86.3241 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 85.798 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 99.8348 | 75 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 94.3949 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 86.2618 | 73 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 93.6475 | 74 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 98.4219 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 81.6931 | 72 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 94.3949 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 83.0186 | 72 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 76.946 | 71 |